Diabetes News

Endocrinology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Kristensen PL et al. - Hypoglycaemia triggers a rise in plasma erythropoietin in patients with type 1 diabetes. The response is influenced by basal RAS activity. Erythropoietin may carry a neuroprotective potential during hypoglycaemia.

Related Articles

Fear of hypoglycaemia: defining a minimum clinically important difference in patients with type 2 diabetes
Health and Quality of Life Outcomes, 10/26/09    Relevance Score: 89%

Phenytoin-facilitated hypoglycaemia in ESRF
British Journal of Renal Medicine, 10/26/09    Relevance Score: 88%

Hyperinsulinaemic hypoglycaemia associated with a heterozygous missense mutation of R1174W in the insulin receptor (IR) gene
Clinical Endocrinology, 10/15/09    Relevance Score: 88%

Angiotensin-converting enzyme and angiotensin II receptor subtype 2 genotypes in type 1 diabetes and severe hypoglycaemia requiring emergency treatment: a case cohort study
Pharmacogenetics and genomics, 10/26/09    Relevance Score: 87%

Hypoglycaemia: An overview
Primary Care Diabetes, 10/20/09    Relevance Score: 87%

Today in Diabetes...keeping you current

New therapies for the treatment of type 2 diabetes: an update
European Diabetes Nursing, 12/18/09

Consumption of restaurant foods and incidence of type 2 diabetes in African American women
American Journal of Clinical Nutrition, 12/18/09

Gestational diabetes mellitus: an opportunity to prevent Type 2 diabetes and cardiovascular disease in young women
Women's Health, 12/18/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address